Zyla Life Sciences Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Zyla Life Sciences had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $4.10 million as of 2019-01-31, per its 10-K filed 2020-03-26.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2020-03-26
- 2019-01-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $4.10M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2019-01-31 | $4.10M 10-K · filed 2020-03-26 |